Regeneron Pharmaceuticals Inc. buy GraveDigger
Start price
16.01.20
/
50%
€353.00
Target price
16.03.20
-
Performance (%)
14.93%
End price
16.03.20
€405.70
Summary
This prediction ended on 16.03.20 with a price of €405.70. The prediction had a final performance of 14.93%. GraveDigger has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | -0.125% | -0.125% | 28.843% | -14.947% |
| iShares Core DAX® | 3.593% | 3.931% | 15.378% | 53.202% |
| iShares Nasdaq 100 | 5.810% | 5.518% | 41.455% | 91.095% |
| iShares Nikkei 225® | 4.075% | 8.460% | 48.947% | 63.933% |
| iShares S&P 500 | 4.142% | 4.039% | 31.594% | 64.840% |
Comments by GraveDigger for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Buy Regeneron Pharmaceuticals Inc.